AQR Capital Management
NERV icon

AQR Capital Management’s Minerva Neurosciences NERV Stock Holding History

AQR Capital Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,603
Closed -$123K – 2294
2021
Q2 		$123K Sell
6,603
-14,899
-69% -$321K ﹤0.01% 2178
2021
Q1 		$502K Sell
21,502
-4,261
-17% -$106K ﹤0.01% 1834
2020
Q4 		$482K Buy
25,763
+2,727
+12% +$68.7K ﹤0.01% 1806
2020
Q3 		$586K Sell
23,036
-15,586
-40% -$421K ﹤0.01% 1653
2020
Q2 		$1.11M Buy
38,622
+32,376
+518% +$1.9M ﹤0.01% 1416
2020
Q1 		$301K Buy
6,246
+4,755
+319% +$287K ﹤0.01% 1764
2019
Q4 		$85K Buy
+1,491
New +$65.8K ﹤0.01% 2092
2019
Q2 		– Sell
-1,285
Closed -$81K – 2141
2019
Q1 		$81K Sell
1,285
-758
-37% -$45.6K ﹤0.01% 2144
2018
Q4 		$110K Buy
+2,043
New +$150K ﹤0.01% 2143
2017
Q4 		– Sell
-2,298
Closed -$140K – 2258
2017
Q3 		$140K Sell
2,298
-2,005
-47% -$115K ﹤0.01% 2209
2017
Q2 		$305K Hold
4,303
– – ﹤0.01% 2030
2017
Q1 		$279K Sell
4,303
-12
-0.3% -$932 ﹤0.01% 2039
2016
Q4 		$406K Buy
4,315
+834
+24% +$85.1K ﹤0.01% 1985
2016
Q3 		$393K Buy
+3,481
New +$338K ﹤0.01% 2011

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management's NERV Position: Q3 2021 in Review

AQR Capital Management sold out of Minerva Neurosciences (NERV) in Q3 2021, closing a stake of 6,603 shares — an estimated $123K sold.

AQR Capital Management first reported a position in NERV in Q3 2016 and held it in 14 quarters. The position peaked at $1.11M in Q2 2020. 46 funds tracked by Wall St. Rank hold NERV as of Q3 2021.

  • AQR Capital Management reported no remaining Minerva Neurosciences position as of Q3 2021 after selling out during the quarter.
  • AQR Capital Management sold 6,603 Minerva Neurosciences shares in Q3 2021, an estimated $123K.
  • AQR Capital Management first reported a position in Minerva Neurosciences in Q3 2016 and held it in 14 quarters.
  • AQR Capital Management's Minerva Neurosciences position peaked at $1.11M in Q2 2020.
  • 46 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2021.

Based on AQR Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.